Peptide receptor radionuclide therapy with 177Lu-DOTATATE in a case of concurrent neuroendocrine tumors and meningioma: achieving two things in a single action
Majid Assadi1, Seyed Javad Rekabpour2, Abdullatif Amini3, Habibollah Dadgar4, Reza Nemati5, Ali Gholamrezanezhad6, Iraj Nabipour7, Esmail Jafari1, Hojjat Ahmadzadehfar81The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran2Department of Oncology, Bushehr Medical University Hospital, Bushehr University of Medical Sciences, Bushehr, Iran
3Department of Cardiology, Bushehr Medical Heart Center, Bushehr University of Medical Sciences, Bushehr, Iran
4Cancer Research Center, RAZAVI Hospital, Imam Reza International University, Mashhad, Iran
5Department of Neurology, Bushehr Medical University Hospital, Bushehr University of Medical Sciences, Bushehr, Iran
6Department of Radiology, Keck School of Medicine, University of Southern California, 1500 San Pablo Street, Los Angeles, CA 90033, USA.
7Department of Internal Medicine (Division of Endocrinology), Bushehr Medical University Hospital, Bushehr University of Medical Sciences, Bushehr, Iran
8Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany
We presented a partial response of peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in a case of concurrent neuroendocrine tumors (NETs) and meningioma. In addition to the valuable role of PRRT in inoperable NETs, it has been shown that this technique could be a promising therapy method in progressive meningioma, especially in patients with low grade and refractory to standard regime.
Keywords: 68Ga-DOTATATE PET/MRI, PRRT, neuroendocrine tumor, 18F-FDG-PET/CTMajid Assadi, Seyed Javad Rekabpour, Abdullatif Amini, Habibollah Dadgar, Reza Nemati, Ali Gholamrezanezhad, Iraj Nabipour, Esmail Jafari, Hojjat Ahmadzadehfar. Peptide receptor radionuclide therapy with 177Lu-DOTATATE in a case of concurrent neuroendocrine tumors and meningioma: achieving two things in a single action. . 2021; 30(2): 107-109
Corresponding Author: Majid Assadi, Iran
Corresponding Author: Majid Assadi, Iran
| TOOLS |
 Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author
Similar articles Google Scholar |